AEGiS-Chicago Tribune: AIDS Virus Successfully Used to Infect Mice in Breakthrough Chicago TribuneImportant note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.
Click here to return to Chicago Tribune main menu
DonateNow


AIDS Virus Successfully Used to Infect Mice in Breakthrough

Chicago Tribune (CT) - FRIDAY December 23, 1988 Edition: FINAL Section: NEWS Page: 4 Word Count: 575
Jon Van, Science writer


A powerful new research weapon to fight AIDS was unveiled Friday by two groups of scientists that have successfully infected mice with the virus that causes the deadly disease.

Until now, the virus that produces acquired immune deficiency syndrome has infected or caused symptoms only in humans. Some chimpanzees have been infected, but they haven't developed symptoms and in any case are a rare endangered species.

In two separate reports published in Friday's edition of the journal Science, researchers describe successfully infecting mice with the human immunodeficiency virus (HIV).

This should be a major advance for AIDS research because it likely will give scientists a means of testing new therapies and vaccines in animals. It also should provide them with new insights into how the virus infects cells and help them find new ways to thwart viral reproduction.

Scientists can do a host of things to lab animals infected with HIV, such as administering potentially dangerous drugs or studying viral activity in their cell tissue, that would be unethical in human patients.

Until now, the lack of a suitable animal model that can be infected with the virus has been a major drag on AIDS research.

The news in Science is especially encouraging because it documents two different approaches to infecting mice with AIDS, a development that should give researchers flexibility for designing future experiments.

A team at Stanford University Medical Center reported AIDS infection of a mouse strain that has no immune system, but into which human immune cells have been implanted. The successful implantation of human immunity into these mice, reported three months ago, had raised hopes that a mouse model for AIDS was on the horizon.

That hope was realized with Friday's announcement.

Another group of scientists at the National Institute of Allergy and Infectious Diseases produces AIDS-infected mice by injecting complete copies of HIV genetic code into mouse eggs and then implanting those eggs into female mice for gestation and birth.

Of 64 animals born from this process, seven contained complete copies of HIV genetic material in all their cells.

These animals, called "transgenic mice," showed no signs of illness, but some of their offspring did exhibit symptoms that are similar to those caused by AIDS in humans.

These mice died of AIDS-like disease.

The full extent to which the two approaches of infecting mice with AIDS will be useful to scientists isn't yet known because the researchers' prime goal was to demonstrate only that mice can be infected with the virus.

At Stanford, for example, there was no sign that the mice developed AIDS or its symptoms because the experiment was terminated after eight weeks so that scientists could study infected cells in the dead mice.

"By limiting the study to eight weeks, we cannot yet predict whether the mice would get the full AIDS syndrome," said Dr. Irving Weissman professor of cancer and pathology at Stanford. "It's too early to tell. This experiment wasn't designed to mimic AIDS (as seen) in human patients exactly."

In the Stanford mice, infection was accomplished by injecting the virus directly into the human immune tissue carried by the animals rather than through sexual intercourse or infection of the blood stream, as are the common infection routes in humans.

At both labs, work with the mice was carried on in high-security areas to guard against infection of lab workers with HIV and against escape from the lab by AIDS infected mice.


Keywords: MEDICINE; DISEASE; ANIMAL; RESEARCH; REPORT

KWDmedicine;disease;animal;research;report
881223
CT881201


Copyright © 1988 - Chicago Tribune. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Chicago Tribune, Permissions Desk, 435 North Michigan Avenue, Chicago, IL 60611  http://www.chicagotribune.com

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.

Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .